Lepu Biopharma Signs CDMO Services Framework Agreement with Lepu Medical
I'm PortAI, I can summarize articles.
Lepu Biopharma Co. Ltd. has signed a CDMO Services Framework Agreement with Lepu Medical to provide contract development and manufacturing services. This agreement supports Lepu Medical's clinical trial development and production registration needs, including clinical drug supply and batch production. The agreement specifies service volumes and costs based on Lepu Medical's requirements. The original content was published by Lepu Biopharma via the Hong Kong Stock Exchange's Issuer Information Service.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments